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Coccidioidomycosis (“pseudotu
sive fungal infection caused by 
immitis and C. posadasii). It is
acquired in Australia, being end
sph re deserts, primarily in the so
States, and Mexico. After respiratImported pathogens are increasingly recognised as poten-
tial biosecurity concerns, but may be overlooked when the
clinical syndrome and causative organism are unexpected.
This case highlights the need to consider an infectious
aetiology in an older migrant with a chronic inflammatory
monoarthritis. It emphasises the need for good communi-
cation between laboratory disciplines, and demonstrates
preliminary success with a combined surgical–medical–
pathology–pharmacological approach.
berculosis”) is an inva-
Coccidioides species (C.
 not autochthonously
emic to western-hemi-
uth-west of the United
ory inoculation, arthro-
conidia (hyphal forms) transform into multinucleated
spherules, which rupture, propagating new spherules.5
Crucial diagnostic information obtained through the his-
topathological detection of spherules in this patient (Box
2) was rapidly relayed to the microbiology laboratory.
Coccidioides spp are classified as Risk Group 3 pathogens
in Australia (as is Bacillus anthracis).6 Analytical work
performed on these pathogens must be carried out in a
biological safety cabinet in a physical containment level 3
sealed laboratory with negative air pressure.6 As one of the
ten most common laboratory-acquired infections,7 with
laboratory attack rates exceeding those of natural expo-
sure,8 travel history to an endemic area is crucial informa-
tion for laboratory staff.3,9 Suspected C. immitis colonies
take up to 5 days to manifest with “typical” morphological
Clinical record
An 81-year-old non-English-speaking Filipino woman with type 2 
diabetes mellitus presented with left knee pain and swelling of 18 
months’ duration. Her mobility was restricted to less than 2m because 
of pain. Synovial fluid obtained by needle aspiration during a recent 
visit to the Philippines had yielded a white cell count of 12200 cells/L 
(55% polymorphonucleocytes; reference interval [RI] not available) 
and no bacterial organisms. On her return to Australia, she was 
referred to an orthopaedic surgeon. Physical examination revealed 
chronically discharging wounds at previous aspiration sites of the 
medial and lateral aspects of the knee, which was swollen and tender 
but with good range of movement. The patient did not have a fever, 
and her C-reactive protein level was 18 mg/L (RI, < 10 mg/L)]. 
Magnetic resonance imaging demonstrated florid erosive synovitis, 
considered most consistent with rheumatoid or seronegative arthritis, 
although bone oedema was noted, suggesting osteomyelitis (Box 1). 
Culture of material from the sinuses for bacteria was negative.
The first stage (debridement, spacer implantation and intravenous 
antibiotic therapy for 4 weeks) of a planned two-stage total knee 
replacement was performed. The patient received intraoperative and 
postoperative empirical treatment with vancomycin. Consultation 
with infectious diseases physicians was then sought. Microscopic 
examination of intraoperative specimens for bacteria, fungi and 
mycobacteria revealed no organisms. However, histopathological 
examination revealed numerous epithelioid granulomata with 
scattered multinucleated giant cells and a dense chronic lymphocytic 
inflammatory infiltrate. Some giant cells contained structures 20–
100m in diameter, characteristic of fungal spherules in various 
stages of development. The spherules had slightly refractile rigid 
walls highly suggestive of Coccidioides species (Box 2).
Five intraoperative specimens inoculated on Sabouraud dextrose 
agar grew a white fluffy fungus on Day 2 of incubation. Sparse clinical 
specimen information, together with rapid colony growth meant 
Coccidioides spp were not suspected before histopathological 
diagnosis, and colonies were manipulated on open laboratory 
benches. Subsequent safety concerns about working with cultures of 
Coccidioides spp warranted killing of the organism with heat before 
further examination.
Coccidioides immitis was identified by polymerase chain reaction 
(PCR) and DNA sequencing. Specifically, the D1-D2 domain of the 
fungal large subunit (28S) ribosomal RNA gene was amplified 
using published primers1 and amplicons sequenced by standard 
methodology. Sequences were subjected to BLASTn search2 and 
compared with archived fungal sequences in the United States 
National Institutes of Health GenBank database.
Expert opinion on management of exposed laboratory staff3 
indicated that the risk in this situation was low (colonies were 
immature and exposure minimal), but warranted prophylaxis. 
Laboratory staff exposed to the fungus were monitored for 
symptoms, prescribed 6 weeks of itraconazole 200 mg twice daily 
for prophylaxis,3 and had immunodiffusion serology performed (in-
house) before and after prophylaxis. All returned negative results.
Subsequently, the patient’s travel history revealed a period of 
residence in Las Vegas, USA, prior to moving to the Philippines. 
Immediately after leaving the US, she had symptoms of a 
respiratory illness. The illness was followed by knee pain and 
swelling. Serology was not performed at any time.
Liposomal amphotericin 4 mg/kg daily was commenced and was 
replaced with oral itraconazole 200 mg twice daily when whole-
body bone scanning and chest imaging revealed no other foci 
of infection. The second stage of the joint replacement (removal 
of spacer and insertion of a prosthetic joint) was undertaken 
4 weeks later.
The operative wound healed well, clinical evidence of infection 
resolved and the patient became ambulant. Her trough serum 
itraconazole levels, initially low at 478g/L (target, > 500g/L4), 
increased to 977g/L with a dosage of 300 mg twice daily. After 4 
weeks of therapy, itraconazole toxicity occurred (3 325g/L 
[maximum trough therapeutic level, < 2000g/L4]) manifested 
by anorexia and hypokalaemia (serum potassium, 2.6 mmol/L 
[RI, 3.2–5.0 mmol/L]) and was successfully managed with dose 
reduction and ongoing therapeutic drug monitoring. Neither toxicity 
nor evidence of infection has recurred after 9 months of long-term 
suppressive itraconazole therapy. ◆705MJA 196 (11) · 18 June 2012
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In our patient, it is highly likely that infection was
acquired in the south-west US about 18 months earlier,
accounting for her pneumonic illness, which occurs in 40%
of infected immunocompetent patients.10 A thorough his-
tory including travel should be obtained; for non-English-
speaking patients, this should be through a professional
interpreter. The history of residence in the US might have
raised suspicion of coccidioidomycosis sooner. Our
patient’s ethnicity and age might have facilitated subse-
quent osteoarticular spread.10 Although less than 5% of
infected patients develop dissemination, it is significantly
more likely in Filipino people, possibly related to the HLA
class II DRB1*1301 allele, or blood group.10 Diabetes
mellitus is not a recognised risk factor for dissemination.
Common extrapulmonary sites of infection are bone,
joint, skin and brain. The knee is the most common
osteoarticular site of infection.8,10 Failure to grow the
organism from initial knee aspirates may have been
because of sequestered organisms in the synovium or
bone, or the failure to request fungal cultures. Prolonged
diagnostic delay led to advanced chronic arthritis. The
presence of multiple discharging sinuses, relatively low C-
reactive protein level and negative bacterial cultures in a
native knee, combined with this patient’s ethnicity and
age, should have raised suspicion of an atypical infective
process (eg, mycobacterial, fungal). Differential diagnoses
include non-infective erosive arthritides (rheumatoid,
seronegative, gout). Preoperative diagnosis could have
permitted earlier adjunctive antifungal therapy.
Aggressive debridement and removal of infected syn-
ovium is recommended for optimal outcomes.8 In this case,
a modified two-stage replacement arthroplasty was under-
taken. As incomplete surgical debridement was suspected,
long-term suppressive antifungal therapy was continued.
Itraconazole was used because of its efficacy against C.
immitis11 and its superiority over fluconazole in skeletal
infection.8 As this case shows, the pharmacokinetics of
itraconazole are complex, and therapeutic drug monitoring
is recommended to optimise dosing.4,8,11 Toxicity requiring
discontinuation is rare (4%); nausea or vomiting is the most
common adverse event (10%), and hypokalaemia occurs in
about 6% of patients.12 In our patient, toxicity developed
after subtherapeutic steady-state trough levels prompted a
dose increase. Variable absorption and the long half-life (20–
30 hours) may also have contributed to dosing difficulties.
Fluconazole, voriconazole or posaconazole are second-
line options.11 Amphotericin formulations are used for
serious infections such as meningitis.11 Susceptibility test-
ing is not routinely performed, to limit handling of the
organism5 and because susceptibility is predictable.
We emphasise the importance of travel history to all
clinicians, from the bedside to the laboratory, in this
uncommon cause of inflammatory monoarthritis. Knowl-
edge of prior residence in a coccidioidal-endemic area, if
included on the specimen request form, would have miti-
gated laboratory exposure, although it may not have led to
preoperative diagnosis. Multidisciplinary input contributed
to a satisfactory early outcome.
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Lessons from practice
• In an older migrant, infection 
should be strongly considered 
as part of the differential 
diagnosis for inflammatory 
monoarthritis, even when 
initially culture-negative.
• Travel history is critically 
important to both clinicians 
and diagnostic laboratory staff.
• Prompt communication and 
collaboration between 
pathology laboratories can 
expedite diagnosis and 
mitigate hazard.
• Therapeutic drug monitoring of 
itraconazole is required due to 
its complex pharmacokinetics 
and bioavailability. ◆11) · 18 June 2012
